Azathioprine did not outperform standard treatment in helping adults with myasthenia gravis (MG) live longer, and while older age alone increased the risk of death, using azathioprine for many years was linked to serious blood problems and cases of cancer, a study has found. However, “although the use of…
News
Povetacicept, a treatment for autoimmune diseases in the pipeline of Vertex Pharmaceuticals, reduced disease activity in a study with a mouse model of myasthenia gravis (MG) by lowering the levels of disease-causing antibodies in the bloodstream. Researchers also observed that povetacicept outperformed efgartigimod — approved as Vyvgart…
Treatment with Vyvgart (efgartigimod) eased hard-to-treat symptoms for a trio of women with generalized myasthenia gravis (gMG) who tested negative for three antibodies commonly seen in the disease, according to a case series from China. Per the researchers, “this report describes three patients with triple-[seronegative] gMG successfully treated with efgartigimod,”…
Vor Bio has signed an exclusive license agreement to develop and market Remegen’s telitacicept — a B-cell-targeting candidate for the treatment of myasthenia gravis (MG) and other autoimmune diseases driven by self-reactive antibodies — outside of China, Hong Kong, Macau, and Taiwan. Telitacicept has been approved…
Athena Sanchez graduates from Northern Arizona University. (Courtesy of Athena Sanchez) This is Athena Sanchez’s story: Living with myasthenia gravis (MG) is like constantly fighting a battle, and my body doesn’t always show up. I was diagnosed when I was just 18, barely out of high…
Jennifer Crow, who lives with MG, says she no longer silences herself. (Courtesy of Jennifer Crow) This is Jennifer Crow’s story: When I was first diagnosed with myasthenia gravis (MG), I thought having a name for my condition would unlock care and put me on the path to…
Telitacicept, a B-cell-targeting therapy for myasthenia gravis (MG), has been granted orphan drug status in the European Union, according to its developer Remegen. Orphan drug designation, or ODD, is awarded to medications that treat conditions affecting fewer than 5 in 10,000 people in the EU. The designation’s…
Mohammed Hanafi and Sarah Bendiff, seen here at a shooting range in Algeria, where they live, have together learned how to adapt to life with MG. (Photo courtesy of Sarah Bendiff) Note: Mohammed Hanafi’s girlfriend Sarah Bendiff is a Myasthenia Gravis News columnist who writes about her journey…
Yvette Bernal, left, with her daughter Eliza Roman as Eliza prepares to graduate high school. (Photo courtesy of Yvette Bernal) This is Yvette Bernal’s story: During my senior year of high school, I found out I was pregnant with a girl. I promised myself I was going to work…
Charlotte Laycock receives a plasma exchange to help control her myasthenia gravis. (Photos courtesy of Charlotte Laycock) This is Charlotte Laycock’s story: Being diagnosed with generalized myasthenia gravis (MG) in my early 30s was something I never expected. At the time, I was living a fast-paced single life…
Recent Posts
- Guest Voice: My MG diagnosis led me to become a patient researcher
- Not asking anymore why I developed myasthenia gravis
- Global trial validates self-administered treatment for myasthenia gravis
- Reflecting on decades of rich history that led to our modern MG treatments
- Immune system activity varies across MG subtypes, study finds